Ketogenic Diets and their Therapeutic Potential on Breast Cancer: A Systemic Review

References

• American Cancer Society. Breast Cancer Facts & Figures 2019–2020. Atlanta: American Cancer Society, Inc; 2019.
   Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. PMID: 32133645. doi:10.3322/caac.21601.32133645
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African Americans. CA Cancer J Clin. 2019. doi:10.3322/caac.21583
   Web of Science ®Google Scholar
• Feng Y, Spezia M, Huang S, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77–106. doi:10.1016/j.gendis.2018.05.00130258937
   PubMed Web of Science ®Google Scholar
• McKenzie AL, Hallberg SJ, Creighton BC, et al. A novel intervention including individualized nutritional recommendations reduces hemoglobin A1c level, medication use, and weight in Type 2 diabetes. JMIR Diabetes. 2017;2(1):e5. doi:10.2196/diabetes.6981.30291062
   PubMedGoogle Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. PMID: 13298683. doi:10.1126/science.123.3191.309.13298683
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. PMID: 21376230. doi:10.1016/j.cell.2011.02.013.21376230
   PubMed Web of Science ®Google Scholar
• Li W, Xu M, Li Y, et al. Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer. J Transl Med. 2020;18(1):92. PMID: 32070368; PMCID: PMC7029444. doi:10.1186/s12967-020-02267-2.32070368
   PubMed Web of Science ®Google Scholar
• Allen BG, Bhatia SK, Anderson CM, et al. Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism. Redox Biol. 2014;2:963–970. PMID: 25460731; PMCID: PMC4215472. doi:10.1016/j.redox.2014.08.002.25460731
   PubMed Web of Science ®Google Scholar
• Westman EC, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab. 2008;5:36. PMID: 19099589; PMCID: PMC2633336. doi:10.1186/1743-7075-5-36.
   Google Scholar
• Maurer GD, Brucker DP, Bähr O, et al. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer. 2011;11:315. PMID: 21791085; PMCID: PMC3199865. doi:10.1186/1471-2407-11-31521791085
   PubMed Web of Science ®Google Scholar
• Zou Y, Fineberg S, Pearlman A, Feinman RD, Fine EJ. The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer. PLoS One. 2020;15(12):e0233662. PMID: 33270630; PMCID: PMC7714189. doi:10.1371/journal.pone.023366233270630
   PubMed Web of Science ®Google Scholar
• Nakamura K, Tonouchi H, Sasayama A, Ashida K. A ketogenic formula prevents tumor progression and cancer cachexia by attenuating systemic inflammation in colon 26 tumor-bearing mice. Nutrients. 2018;10(2):206. PMID: 29443873; PMCID: PMC5852782. doi:10.3390/nu10020206
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Augur ZM, Li M, et al. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma. Commun Biol. 2019;2:200. PMID: 31149644; PMCID: PMC6541653. doi:10.1038/s42003-019-0455-x31149644
   PubMed Web of Science ®Google Scholar
• Giordano C, Marchiò M, Timofeeva E, Biagini G. Neuroactive peptides as putative mediators of antiepileptic ketogenic diets. Front Neurol. 2014;5:63. PMID: 24808888; PMCID: PMC4010764. doi:10.3389/fneur.2014.0006324808888
   PubMed Web of Science ®Google Scholar
• Prabhakar A, Quach A, Zhang H, et al. Acetone as biomarker for ketosis buildup capability–a study in healthy individuals under combined high fat and starvation diets. Nutr J. 2015;14:41. PMID: 25897953; PMCID: PMC4471925. doi:10.1186/s12937-015-0028-x25897953
   PubMed Web of Science ®Google Scholar
• Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110:1178–1187. PMID: 23651522. doi:10.1017/S000711451300054823651522
   PubMed Web of Science ®Google Scholar
• Branco AF, Ferreira A, Simões RF, et al. Ketogenic diets: from cancer to mitochondrial diseases and beyond. Eur J Clin Invest. 2016;46(3):285–298. doi:10.1111/eci.1259126782788
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Yu G, Maroon JC, D’Agostino DP. Press-pulse: a novel therapeutic strategy for the metabolic management of cancer. Nutr Metab. 2017;14:19. PMID: 28250801; PMCID: PMC5324220. doi:10.1186/s12986-017-0178-2
   Google Scholar
• Fine EJ, Miller A, Quadros EV, Sequeira JM, Feinman RD. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Int. 2009;9:14. PMID: 19480693; PMCID: PMC2694762. doi:10.1186/1475-2867-9-1419480693
   PubMed Web of Science ®Google Scholar
• Bartmann C, Janaki Raman SR, Flöter J, et al. Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation. Cancer & Metabolism. 2018;6(1):8. doi:10.1186/s40170-018-0180-929942509
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Chan DK, Haugrud AB, Miskimins WK. Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo. PLoS One. 2014;9(9):e108444. PMID: 25254953; PMCID: PMC4177919. doi:10.1371/journal.pone.010844425254953
   PubMed Web of Science ®Google Scholar
• Vidali S, Aminzadeh-Gohari S, Feichtinger RG, et al. The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer’s syndrome. Oncotarget. 2017;8(34):57201–57215. PMID: 28915665; PMCID: PMC5593636. doi:10.18632/oncotarget.1930628915665
   PubMedGoogle Scholar
• Otto C, Kaemmerer U, Illert B, et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer. 2008;8:122. PMID: 18447912; PMCID: PMC2408928. doi:10.1186/1471-2407-8-12218447912
   PubMed Web of Science ®Google Scholar
• Senapati P, Kato H, Lee M, et al. Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer. Epigenetics Chromatin. 2019;12(1):44. PMID: 31315653; PMCID: PMC6636093. doi:10.1186/s13072-019-0290-931315653
   PubMed Web of Science ®Google Scholar
• Hopkins BD, Pauli C, Du X, et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018;560(7719):499–503. PMID: 30051890; PMCID: PMC6197057. doi:10.1038/s41586-018-0343-430051890
   PubMed Web of Science ®Google Scholar
• Nagini S, Sophia J, Mishra R. Glycogen synthase kinases: moonlighting proteins with theranostic potential in cancer. Semin Cancer Biol. 2019;56:25–36. PMID: 29309927. doi:10.1016/j.semcancer.2017.12.01029309927
   PubMed Web of Science ®Google Scholar
• Thakur B, Kumar Y, Bhatia A. Programmed necrosis and its role in management of breast cancer. Pathol Res Pract. 2019;215(11):152652. PMID: 31570277. doi:10.1016/j.prp.2019.15265231570277
   PubMed Web of Science ®Google Scholar
• Shimazu T, Hirschey MD, Newman J, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211–214. PMID: 23223453; PMCID: PMC3735349. doi:10.1126/science.122716623223453
   PubMed Web of Science ®Google Scholar
• Wilson AJ, Chueh AC, Tögel L, et al. Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Res. 2010;70(2):609–620. PMID: 20068171; PMCID: PMC2939837. doi:10.1158/0008-5472.CAN-09-232720068171
   PubMed Web of Science ®Google Scholar
• Fine E, Zou Y, Koba W. FDG-PET of mouse breast cancers on ketogenic vs. standard chow diets, with or without added rapamycin. J Nucl Med. 2019;60(supplement 1):280.
   Google Scholar
• Arruebo M, Vilaboa N, Sáez-Gutierrez B, et al. Assessment of the evolution of cancer treatment therapies. Cancers. 2011;3(3):3279–3330. PMID: 24212956; PMCID: PMC3759197. doi:10.3390/cancers303327924212956
   PubMedGoogle Scholar
• Iyikesici MS, Slocum AK, Slocum A, Berkarda FB, Kalamian M, Seyfried TN. Efficacy of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy for stage iv triple-negative breast cancer. Cureus. 2017;9(7):e1445. PMID: 28924531; PMCID: PMC5589510. doi:10.7759/cureus.144528924531
   PubMed Web of Science ®Google Scholar
• Weber DD, Aminazdeh-Gohari S, Kofler B. Ketogenic diet in cancer therapy. Aging. 2018;10(2):164–165. PMID: 29443693; PMCID: PMC5842847. doi:10.18632/aging.10138229443693
   PubMedGoogle Scholar
• Khodabakhshi A, Akbari ME, Mirzaei HR, Seyfried TN, Kalamian M, Davoodi SH. Effects of Ketogenic metabolic therapy on patients with breast cancer: a randomized controlled clinical trial. Clin Nutr. 2021;40:751–758. PMID: 32703721. doi:10.1016/j.clnu.2020.06.02832703721
   PubMed Web of Science ®Google Scholar
• Khodabakhshi A, Akbari ME, Mirzaei HR, Mehrad-Majd H, Kalamian M, Davoodi SH. Feasibility, safety, and beneficial effects of MCT-based ketogenic diet for breast cancer treatment: a Randomized Controlled Trial Study. Nutr Cancer. 2020;72(4):627–634. PMID: 31496287. doi:10.1080/01635581.2019.165094231496287
   PubMed Web of Science ®Google Scholar
• Wang Y, Jing MX, Jiang L, et al. Does a ketogenic diet as an adjuvant therapy for drug treatment enhance chemotherapy sensitivity and reduce target lesions in patients with locally recurrent or metastatic Her-2-negative breast cancer? Study protocol for a randomized controlled trial. Trials. 2020;21(1):487. PMID: 32503654; PMCID: PMC7275564. doi:10.1186/s13063-020-04429-532503654
   PubMed Web of Science ®Google Scholar
• Klement RJ, Brehm N, Sweeney RA. Ketogenic diets in medical oncology: a systematic review with focus on clinical outcomes. Med Oncol. 2020;37(2):1–2. doi:10.1007/s12032-020-1337-2
   Web of Science ®Google Scholar
• Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16(10):635–649. PMID: 27634447; PMCID: PMC5516800. doi:10.1038/nrc.2016.7727634447
   PubMed Web of Science ®Google Scholar
• Reis LMD, Adamoski D, Ornitz Oliveira Souza R, et al. Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells. J Biol Chem. 2019;294(24):9342–9357. PMID: 31040181; PMCID: PMC6579458. doi: 10.1074/jbc.RA119.00818031040181
   PubMed Web of Science ®Google Scholar
• Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - Where do we stand? Mol Metab. 2020;33:102–121. PMID: 31399389; PMCID: PMC7056920. doi:10.1016/j.molmet.2019.06.02631399389
   PubMed Web of Science ®Google Scholar
• Pitroda SP, Wakim BT, Sood RF, et al. STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect. BMC Med. 2009;7:68. PMID: 19891767; PMCID: PMC2780454. doi:10.1186/1741-7015-7-6819891767
   PubMed Web of Science ®Google Scholar
• Janku F. Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: from laboratory to patients. Cancer Treat Rev. 2017;59:93–101. PMID: 28779636. doi:10.1016/j.ctrv.2017.07.00528779636
   PubMed Web of Science ®Google Scholar
• Jansen N, Walach H. The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: a case series in general practice. Oncol Lett. 2016;11(1):584–592. PMID: 26870251; PMCID: PMC4726921. doi:10.3892/ol.2015.392326870251
   PubMed Web of Science ®Google Scholar
• Owens KM, Kulawiec M, Desouki MM, Vanniarajan A, Singh KK. Impaired OXPHOS complex III in breast cancer. PLoS One. 2011;6(8):e23846. PMID: 21901141; PMCID: PMC3162009. doi:10.1371/journal.pone.002384621901141
   PubMed Web of Science ®Google Scholar
• Arismendi-Morillo G, Castellano-Ramírez A, Seyfried TN. Ultrastructural characterization of the Mitochondria-associated membranes abnormalities in human astrocytomas: functional and therapeutics implications. Ultrastruct Pathol. 2017;41(3):234–244. PMID: 28375672. doi:10.1080/01913123.2017.130061828375672
   PubMed Web of Science ®Google Scholar
• Morciano G, Marchi S, Morganti C, et al. Role of mitochondria-associated er membranes in calcium regulation in cancer-specific settings. Neoplasia. 2018;20(5):510–523. PMID: 29626751; PMCID: PMC5916088. doi:10.1016/j.neo.2018.03.00529626751
   PubMed Web of Science ®Google Scholar
• Aminzadeh-Gohari S, Feichtinger RG, Vidali S, et al. A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model. Oncotarget. 2017;8(39):64728–64744. PMID: 29029389; PMCID: PMC5630289. doi:10.18632/oncotarget.2004129029389
   PubMedGoogle Scholar
• Tagliabue A, Bertoli S, Trentani C, Borrelli P, Veggiotti P. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: a 6-month prospective observational study. Clin Nutr. 2012;31(2):246–249. PMID: 22019282. doi:10.1016/j.clnu.2011.09.01222019282
   PubMed Web of Science ®Google Scholar
• Volek JS, Freidenreich DJ, Saenz C, et al. Metabolic characteristics of keto-adapted ultra-endurance runners. Metabolism. 2016;65(3):100–110. PMID: 26892521. doi:10.1016/j.metabol.2015.10.02826892521
   PubMed Web of Science ®Google Scholar
• Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med. 2017;104:144–164. PMID: 28088622. doi:10.1016/j.freeradbiomed.2017.01.00428088622
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Mukherjee P, Iyikesici MS, et al. Consideration of ketogenic metabolic therapy as a complementary or alternative approach for managing breast cancer. Front Nutr. 2020;7:21. PMID: 32219096; PMCID: PMC7078107. doi:10.3389/fnut.2020.0002132219096
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med. 2013;3(8):a014217. PMID: 23906881; PMCID: PMC3721271. doi:10.1101/cshperspect.a01421723906881
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Narisada H, et al. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results. Int J Hyperthermia. 2009;25(2):160–167. PMID: 19337916. doi:10.1080/0265673080261035719337916
   PubMed Web of Science ®Google Scholar
• Poff AM, Ward N, Seyfried TN, Arnold P, D’Agostino DP. Non-toxic metabolic management of metastatic cancer in VM mice: novel combination of ketogenic diet, ketone supplementation, and hyperbaric oxygen therapy. PLoS One. 2015;10(6):e0127407. PMID: 26061868; PMCID: PMC4464523. doi:10.1371/journal.pone.012740726061868
   PubMed Web of Science ®Google Scholar
• Klement RJ. The emerging role of ketogenic diets in cancer treatment. Curr Opin Clin Nutr Metab Care. 2019;22(2):129–134. doi:10.1097/MCO.000000000000054030531479
   PubMed Web of Science ®Google Scholar
• Iyikesici MS. Feasibility study of metabolically supported chemotherapy with weekly carboplatin/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer. Int J Hyperthermia. 2019;36:446–455. PMID: 30931666. doi:10.1080/02656736.2019.158958430931666
   PubMed Web of Science ®Google Scholar
• Elsakka AMA, Bary MA, Abdelzaher E, et al. Management of glioblastoma multiforme in a patient treated with ketogenic metabolic therapy and modified standard of care: a 24-month follow-up. Front Nutr. 2018;5:20. PMID: 29651419; PMCID: PMC5884883. doi:10.3389/fnut.2018.0002029651419
   PubMed Web of Science ®Google Scholar